Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/39078
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWILLEMS, Emily-
dc.contributor.authorSCHEPERS, Melissa-
dc.contributor.authorAit-Tihyaty, M.-
dc.contributor.authorVANMIERLO, Tim-
dc.date.accessioned2022-12-19T10:43:04Z-
dc.date.available2022-12-19T10:43:04Z-
dc.date.issued2022-
dc.date.submitted2022-12-09T13:48:18Z-
dc.identifier.citationMultiple Sclerosis Journal, 28 (S3) , p. 351 -352-
dc.identifier.urihttp://hdl.handle.net/1942/39078-
dc.description.sponsorshipMS, EW ad TV report no competing interest. MAT is an employee of Janssen and may own stock or stock options in Johnson & Johnson.-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.titlePonesimod, mono-selective sphingosine-1-phosphate receptor 1 modulator enhances oligodendrocyte precursor cell differentiation-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateOCT 26-28, 2022-
local.bibliographicCitation.conferencename38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis-
local.bibliographicCitation.conferenceplaceAmsterdam, NETHERLANDS-
dc.identifier.epage352-
dc.identifier.issueS3-
dc.identifier.spage351-
dc.identifier.volume28-
local.format.pages2-
local.bibliographicCitation.jcatM-
local.publisher.place1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi000866540801318-
local.provider.typewosris-
local.description.affiliation[Willems, E.; Schepers, M.; Vanmierlo, T.] Hasselt Univ, Biomed Res Inst, Dept Neurosci, Hasselt, Belgium.-
local.description.affiliation[Willems, E.; Schepers, M.; Vanmierlo, T.] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat Neuropsychol, Maastricht, Netherlands.-
local.description.affiliation[Ait-Tihyaty, M.] LLC, Janssen Res Dev, Titusville, FL USA.-
local.uhasselt.internationalyes-
item.fulltextWith Fulltext-
item.fullcitationWILLEMS, Emily; SCHEPERS, Melissa; Ait-Tihyaty, M. & VANMIERLO, Tim (2022) Ponesimod, mono-selective sphingosine-1-phosphate receptor 1 modulator enhances oligodendrocyte precursor cell differentiation. In: Multiple Sclerosis Journal, 28 (S3) , p. 351 -352.-
item.accessRightsOpen Access-
item.contributorWILLEMS, Emily-
item.contributorSCHEPERS, Melissa-
item.contributorAit-Tihyaty, M.-
item.contributorVANMIERLO, Tim-
crisitem.journal.issn1352-4585-
crisitem.journal.eissn1477-0970-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Ponesimod, mono-selective sphingosine-1-phosphate receptor 1 modulator enhances oligodendrocyte precursor cell differentiation.pdfPublished version4.41 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.